Engelgau, Michael M.
13 papers on CoChat
Most cited papers
- Verified · note
Effectiveness of Self-Management Training in Type 2 Diabetes
Norris, S. L., Engelgau, M. M., & Venkat Narayan, K. M. (2001) · Diabetes Care
Diabetes Management and EducationDiabetes Management and Research
Cited by 1,846
- Verified · note
Self-Management Education for Adults With Type 2 Diabetes
Norris, S. L., Lau, J., Smith, S. J., Schmid, C. H., & Engelgau, M. M. (2002) · Diabetes Care
Diabetes Management and EducationDiabetes Management and Research
Cited by 1,750
- Verified
Priority actions for the non-communicable disease crisis
Beaglehole, R., Bonita, R., Horton, R., Adams, C., Alleyne, G., Asaria, P., Baugh, V., Bekedam, H., Billo, N., Casswell, S., et al. (2011) · The Lancet
Global Public Health Policies and EpidemiologyGlobal Health and Epidemiology
Cited by 1,615
- Verified
Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population
Cowie, C. C., Rust, K. F., Byrd-Holt, D. D., Eberhardt, M. S., Flegal, K. M., Engelgau, M. M., Saydah, S. H., Williams, D. E., Geiss, L. S., & Gregg, E. W. (2006) · Diabetes Care
Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Research
Cited by 1,210
- Verified
Diabetes trends in the U.S.: 1990-1998.
Mokdad, A. H., Ford, E. S., Bowman, B. A., Nelson, D. E., Engelgau, M. M., Vinicor, F., & Marks, J. S. (2000) · Diabetes Care
Diabetes, Cardiovascular Risks, and LipoproteinsObesity, Physical Activity, Diet
Cited by 1,042
- Verified
The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance
Herman, W. H., Hoerger, T. J., Brandle, M., Hicks, K., Sorensen, S., Zhang, P., Hamman, R. F., Ackermann, R. T., Engelgau, M. M., Ratner, R. E., et al. (2005) · Annals of Internal Medicine
Health Systems, Economic Evaluations, Quality of LifeDiabetes Treatment and Management
Cited by 703
- Verified
Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention study: A 23-year follow-up study
Li, G., Zhang, P., Wang, J., An, Y., Gong, Q., Gregg, E. W., Yang, W., Zhang, B., Shuai, Y., Hong, J., et al. (2014) · The Lancet Diabetes & Endocrinology
Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management
Cited by 684
- Verified
Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study
Gong, Q., Zhang, P., Wang, J., Ma, J., An, Y., Chen, Y., Zhang, B., Feng, X., Li, H., Chen, X., et al. (2019) · The Lancet Diabetes & Endocrinology
Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management
Cited by 615
- Verified
Identifying Persons with Diabetes Using Medicare Claims Data
Hebert, P. L., Geiss, L. S., Tierney, E. F., Engelgau, M. M., Yawn, B. P., & McBean, A. M. (1999) · American Journal of Medical Quality
Medical Coding and Health InformationChronic Disease Management Strategies
Cited by 403
- Verified
Comparison of fasting and 2-hour glucose and HbA1c levels for diagnosing diabetes. Diagnostic criteria and performance revisited
Engelgau, M. M., Thompson, T. J., Herman, W. H., Boyle, J. P., Aubert, R. E., Kenny, S. J., Badran, A., Sous, E. S., & Ali, M. A. (1997) · Diabetes Care
Diabetes Management and ResearchDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 325
- Verified
Changes in incidence of diabetes in U.S. adults, 1997–2003
Geiss, L. S., Pan, L., Cadwell, B., Gregg, E. W., Benjamin, S. M., & Engelgau, M. M. (2006) · American Journal of Preventive Medicine
Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Research
Cited by 229
- Verified
Screening for type 2 diabetes mellitus: a cost-effectiveness analysis
Hoerger, T. J., Harris, R., Hicks, K. A., Donahue, K., Sorensen, S., & Engelgau, M. (2004) · Annals of Internal Medicine
Health Systems, Economic Evaluations, Quality of LifeHealth Promotion and Cardiovascular Prevention
Cited by 178
- Verified
Cardiovascular, respiratory, and related disorders: key messages from Disease Control Priorities, 3rd edition
Prabhakaran, D., Anand, S., Watkins, D., Gaziano, T., Wu, Y., Mbanya, J. C., Nugent, R., Ajay, V. S., Afshin, A., Adler, A., et al. (2018) · The Lancet
Cardiovascular Health and Risk FactorsGlobal Public Health Policies and Epidemiology
Cited by 162
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free